Lyell ImmunopharmaLYEL 
$1.35-2.88%24h
-2.88%24h
Global rank13883
Market cap$340.02M
Change 7d10.66%
YTD Performance-30.41%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of Lyell Immunopharma (LYEL)
As of November 2024, Lyell Immunopharma has a market cap of $340.02M. This makes Lyell Immunopharma the world's 13883th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Lyell Immunopharma from 2021 to 2024
-
Value:-
Market cap history of Lyell Immunopharma from 2021 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $459.66M | -5.93% |
| 2023 | $488.63M | -44.09% |
| 2022 | $873.99M | -55.17% |
| 2021 | $1.95B | - |
LYEL Market Cap Today is $340.02M -2.88% - 22 Nov 2024
View largest stocks by market cap 
